These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1652099)

  • 41. Selecting T cell receptors with high affinity for self-MHC by decreasing the contribution of CD8.
    Sherman LA; Hesse SV; Irwin MJ; La Face D; Peterson P
    Science; 1992 Oct; 258(5083):815-8. PubMed ID: 1439792
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Species-restricted interactions between CD8 and the alpha 3 domain of class I influence the magnitude of the xenogeneic response.
    Irwin MJ; Heath WR; Sherman LA
    J Exp Med; 1989 Oct; 170(4):1091-101. PubMed ID: 2477484
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immune evasion proteins of human cytomegalovirus do not prevent a diverse CD8+ cytotoxic T-cell response in natural infection.
    Manley TJ; Luy L; Jones T; Boeckh M; Mutimer H; Riddell SR
    Blood; 2004 Aug; 104(4):1075-82. PubMed ID: 15039282
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A single peptide-MHC complex positively selects a diverse and specific CD8 T cell repertoire.
    Wang B; Primeau TM; Myers N; Rohrs HW; Gross ML; Lybarger L; Hansen TH; Connolly JM
    Science; 2009 Nov; 326(5954):871-4. PubMed ID: 19892989
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cross-reactivity of cytomegalovirus-specific CD8+ T cells to allo-major histocompatibility complex class I molecules.
    Gamadia LE; Remmerswaal EB; Surachno S; Lardy NM; Wertheim-van Dillen PM; van Lier RA; ten Berge IJ
    Transplantation; 2004 Jun; 77(12):1879-85. PubMed ID: 15223907
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Origin and plasticity of MHC I-associated self peptides.
    de Verteuil D; Granados DP; Thibault P; Perreault C
    Autoimmun Rev; 2012 Jul; 11(9):627-35. PubMed ID: 22100331
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Mechanisms in evasion of host immune response by HCMV].
    Satoh T; Arase H
    Nihon Rinsho; 2006 Mar; 64 Suppl 3():421-6. PubMed ID: 16615508
    [No Abstract]   [Full Text] [Related]  

  • 48. Immunogenicity of two peptide determinants in the cytolytic T-cell response to flavivirus infection: inverse correlation between peptide affinity for MHC class I and T-cell precursor frequency.
    Regner M; Müllbacher A; Blanden RV; Lobigs M
    Viral Immunol; 2001; 14(2):135-49. PubMed ID: 11398809
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The peptide p2Ca is immunodominant in allorecognition of Ld by beta chain variable region V beta 8+ but not V beta 8- strains.
    Connolly JM
    Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11482-6. PubMed ID: 7972088
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The thymus leukemia antigen binds human and mouse CD8.
    Teitell M; Mescher MF; Olson CA; Littman DR; Kronenberg M
    J Exp Med; 1991 Nov; 174(5):1131-8. PubMed ID: 1834760
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-influenza virus cytotoxic T lymphocytes recognize the three viral polymerases and a nonstructural protein: responsiveness to individual viral antigens is major histocompatibility complex controlled.
    Bennink JR; Yewdell JW; Smith GL; Moss B
    J Virol; 1987 Apr; 61(4):1098-102. PubMed ID: 3493353
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of MHC class I antigen presentation by viral proteins.
    Früh K; Ahn K; Peterson PA
    J Mol Med (Berl); 1997 Jan; 75(1):18-27. PubMed ID: 9020380
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of Ld-restricted peptides with the wild-derived mouse Lw16 MHC class I molecule.
    Talken BL; Harrison LG; Lee DR
    Mol Immunol; 1994 Aug; 31(12):943-54. PubMed ID: 8065377
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides.
    Suto R; Srivastava PK
    Science; 1995 Sep; 269(5230):1585-8. PubMed ID: 7545313
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structure, function, and diversity of class I major histocompatibility complex molecules.
    Bjorkman PJ; Parham P
    Annu Rev Biochem; 1990; 59():253-88. PubMed ID: 2115762
    [No Abstract]   [Full Text] [Related]  

  • 56. Limit of T cell tolerance to self proteins by peptide presentation.
    Schild H; Rötzschke O; Kalbacher H; Rammensee HG
    Science; 1990 Mar; 247(4950):1587-9. PubMed ID: 2321019
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Solid matrix-antibody-antigen complexes induce antigen-specific CD8+ cells that clear a persistent paramyxovirus infection.
    Randall RE; Young DF
    J Virol; 1991 Feb; 65(2):719-26. PubMed ID: 1898971
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A naturally occurring peptide recognized by alloreactive CD8+ cytotoxic T lymphocytes in association with a class I MHC protein.
    Udaka K; Tsomides TJ; Eisen HN
    Cell; 1992 Jun; 69(6):989-98. PubMed ID: 1606619
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antigen presentation in virus infection.
    Murray N; McMichael A
    Curr Opin Immunol; 1992 Aug; 4(4):401-7. PubMed ID: 1388841
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interleukin-12 as adjuvant in peptide vaccines.
    O'Toole M; Wooters J; Brown E; Swiniarski H; Cull G; Leger L; Herrmann S
    Ann N Y Acad Sci; 1996 Oct; 795():379-81. PubMed ID: 8958960
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.